Market Research Report
Home Infusion Therapy Global Market Report 2022
|Home Infusion Therapy Global Market Report 2022|
The Business Research Company
Content info: 175 Pages
Delivery time: 2-10 business days
“Home Infusion Therapy Global Market Report 2022 ” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global home infusion therapy market.
This report focuses on home infusion therapy market which is experiencing strong growth. The report gives a guide to the home infusion therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Where is the largest and fastest growing market for the home infusion therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Home Infusion Therapy market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider home infusion therapy market, and compares it with other markets.
Markets Covered: 1) By Product: Infusion Pumps; Intravenous Sets; IV Cannulas; Needleless Connectors
2) By Administration: Intramuscular; Subcutaneously; Epidural
3) By Application: Total Parenteral Nutrition; Anti-infective Therapy; Enteral Nutrition; Hydration Therapy; Chemotherapy; IVIg or Specialty Pharmaceuticals; Other Applications
4) By End User: Patients; Nurse; Hospitals; Other End Users
Companies Mentioned: B Braun Melsungen AG; Baxter International, Inc.; Eli Lilly and Company; Fresenius Kabi; Option Care Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Major players in the home infusion therapy market are: B Braun Melsungen AG, Baxter International Inc, Eli Lilly and Company, Fresenius Kabi, Option Care Health Inc, CareCentrix Inc, Caesarea Medical Electronics, JMS Co.Ltd, Terumo Corporation, Smiths Medica, Optum Inc, CVS Health, KabaFusion, PromptCare, and Nipro Corporation.
The global home infusion therapy market is expected to grow from $21.88 billion in 2021 to $24.89 billion in 2022 at a compound annual growth rate (CAGR) of 13.7%. The home infusion therapy market is expected to grow to $36.71 billion in 2026 at a CAGR of 10.2%.
The home infusion therapy market consists of sales of home infusion therapy solutions by entities (organizations, sole traders, and partnerships) that are used to treat individuals at home. Home infusion therapy is a process of subcutaneous or intravenous administration of biologicals or drugs to a person at home. Patients can receive medications through catheters or needles, directly into their veins or under their skin.
The main types of products in home infusion therapy are infusion pumps, intravenous sets, IV cannulas, and needleless connectors. Home infusion pumps are medical devices that deliver medicine into the patient's body in specific, controlled amounts. It controls the rate of replacement fluid infused into the blood outflow line or the blood inflow line. The different administrations include intramuscular, subcutaneously, and epidural that are used in numerous applications such as total parenteral nutrition, anti-infective therapy, enteral nutrition, hydration therapy, chemotherapy, IVIg or specialty pharmaceuticals, and other applications. The several end users include patients, nurses, hospitals, and others.
North America was the largest region in the home infusion therapy market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home infusion therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The home infusion therapy market research report is one of a series of new reports from The Business Research Company that provides home infusion therapy market statistics, including home infusion therapy industry global market size, regional shares, competitors with a home infusion therapy market share, detailed home infusion therapy market segments, market trends and opportunities, and any further data you may need to thrive in the home infusion therapy industry. This home infusion therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The increasing population and consequent rise in food demand are expected to propel the growth of the home infusion therapy market moving forward. Food refers to the substance consisting of protein, carbohydrates, fat, and other nutrients that are used in the body of an organism for sustaining growth and vital processes and furnishing energy. Food is the essential factor for the patients undergoing home infusion therapy, and the increasing population led to an increase in the number of aged people who require home infusion therapy. For instance, according to United Nations data, the world's population has been expected to increase by 2 billion people in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050. Moreover, according to Intechnopen data, a London-based journal website, the global demand for food has been expected to increase by 70% by 2050. Therefore, the increasing population and consequent rise in food demand will drive the growth of the home infusion therapy market.
Strategic partnerships and collaborations have emerged as the key trend gaining popularity in the home infusion therapy market. Major companies operating in the home infusion therapy sector are focused on partnerships to reinforce their position in the market. For instance, in April 2022, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with Mount Sinai Health System, a US-based hospital network. This partnership allows expanding patient access to home infusion therapies across the Mount Sinai Health System, encompassing its eight hospitals and ambulatory footprint. Furthermore, in December 2021, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with the University of Chicago Medicine (UChicago Medicine), a US-based academic medical center. This partnership allows CarepathRx to provide comprehensive home and specialty infusion services to the academic health system's growing patient population. It also helps UChicago Medicine to extend its clinical reach into the home and ambulatory setting.
In March 2021, PromptCare, a US-based specialty home infusion, and complex respiratory services company acquired NBN Infusions Inc, for an undisclosed amount. Through this acquisition, PromptCare aims at strengthening its focus on providing specialty infusion therapies. NBN Infusions Inc is a US-based provider of health care services including home infusion therapy, enteral therapy, and respiratory therapy services.
The countries covered in the home infusion therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.